Clomipramine, Urine
Immunophenotypic Analysis of Tissues by Flow Cytometry
Lead, Random, Urine
Cologaurd®, Cologuard Plus, Stool DNA-Based Colorectal Cancer Screening Test
Chorionic Villus Sampling (CVS)
Hereditary Erythrocytosis Gene Mutation Panel, NGS
ATM/C11orf65 Gene Variation
Acute Hepatitis Panel
Epidermal Nerve Fiber Density (ENFD)
Reiter's disease (reactive arthritis)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Reference Ranges
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now